Breast cancer that has spread to other parts of your body may start to cause new symptoms, depending on the location of the metastases. As symptoms develop or progress, treatment and care may also ...

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.

The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Getting a diagnosis of lung cancer can be scary, especially when you don't know what to expect. To help, experts will guide ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with zoledronic ...

Tumors and other cancers can shed DNA into the bloodstream, distorting the ratios. Sometimes this can lead to alarming ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

Theriva™ (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and ...

The global cancer supportive care drugs market is crucial in enhancing the quality of life and managing symptoms for cancer ...